Rigel Pharmaceuticals Inc (RIGL)

Total Liabilities

$95.42M

Quarterly · Period ending: · USD

RIGL logo

RIGL Total Liabilities

Latest reported$95.42M
RIGL Quarterly Total Liabilities ($15.25M → $95.42M)
High-resolution chart · PNG

RIGL total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rigel Pharmaceuticals Inc Total Liabilities — Quarterly (USD)
Period endingTotal Liabilities (USD)
95,416,000
104,711,000
122,114,000
124,925,000
124,802,000
157,405,000
160,688,000
154,055,000
158,322,000
158,190,000
145,869,000
147,158,000
145,206,000
147,869,000
147,895,000
135,443,000
131,678,000
142,276,000
136,954,000
136,848,000
133,488,000
137,695,000
76,352,000
72,103,000
74,825,000
64,864,000
93,754,000
87,150,000
77,867,000
77,469,000
29,232,000
19,696,000
17,652,000
19,006,000
18,465,000
15,083,000
15,873,000
17,245,000
23,107,000
22,698,000
25,600,000
32,828,000
40,366,000
42,764,000
47,202,000
53,541,000
25,889,000
16,369,000
16,698,000
14,963,000
17,807,000
16,135,000
16,623,000
17,628,000
20,947,000
19,512,000
18,610,000
17,331,000
20,957,000
17,901,000
17,182,000
16,357,000
20,564,000
22,100,000
71,477,000
124,360,000
30,877,000
33,987,000
36,668,000
37,058,000
39,693,000
37,837,000
32,472,000
28,417,000
33,607,000
25,365,000
23,899,000
24,622,000
26,011,000
24,943,000
25,931,000
34,682,000
39,080,000
32,139,000
34,473,000
35,590,000
26,521,000
18,511,000
17,030,000
15,860,000
15,551,000
15,755,000
15,003,000
15,194,000
18,901,000
21,213,000
21,486,000
21,934,000
17,507,000
18,566,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.